VISEN Pharma Adds Three Non-Executive Director Nominees to 26 June 2026 AGM Agenda

Bulletin Express06-17

VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701, 1788 Square, No. 1788 West Nanjing Road, Jing’an District, Shanghai.

Key additions to the AGM agenda: 1. Ordinary Resolutions 2(e)–2(g) propose the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass and Mr. Michael J. Chang as non-executive directors. 2. A revised proxy form—separate from the original proxy form dated 27 April 2026—must be completed for voting on the new resolutions. Submission to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, is required at least 48 hours before the meeting.

The supplemental notice states that all other information in the original AGM notice remains unchanged. Voting on all resolutions will be conducted by poll.

As at the notice date of 17 June 2026, the board comprises one executive director, two non-executive directors and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131412685?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131412685","market":"hk","top_or_hot":-1,"title":"VISEN Pharma Adds Three Non-Executive Director Nominees to 26 June 2026 AGM Agenda","media":"Bulletin Express","content":"<p>VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701, 1788 Square, No. 1788 West Nanjing Road, Jing’an District, Shanghai.</p>\n<p>Key additions to the AGM agenda:  \n1. Ordinary Resolutions 2(e)–2(g) propose the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass and Mr. Michael J. Chang as non-executive directors.  \n2. A revised proxy form—separate from the original proxy form dated 27 April 2026—must be completed for voting on the new resolutions. Submission to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, is required at least 48 hours before the meeting.</p>\n<p>The supplemental notice states that all other information in the original AGM notice remains unchanged. Voting on all resolutions will be conducted by poll.</p>\n<p>As at the notice date of 17 June 2026, the board comprises one executive director, two non-executive directors and four independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>VISEN Pharma Adds Three Non-Executive Director Nominees to 26 June 2026 AGM Agenda</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVISEN Pharma Adds Three Non-Executive Director Nominees to 26 June 2026 AGM Agenda\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-17 23:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701, 1788 Square, No. 1788 West Nanjing Road, Jing’an District, Shanghai.</p>\n<p>Key additions to the AGM agenda:  \n1. Ordinary Resolutions 2(e)–2(g) propose the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass and Mr. Michael J. Chang as non-executive directors.  \n2. A revised proxy form—separate from the original proxy form dated 27 April 2026—must be completed for voting on the new resolutions. Submission to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, is required at least 48 hours before the meeting.</p>\n<p>The supplemental notice states that all other information in the original AGM notice remains unchanged. Voting on all resolutions will be conducted by poll.</p>\n<p>As at the notice date of 17 June 2026, the board comprises one executive director, two non-executive directors and four independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02561","symbol_name":"维昇药业-B","start_time":0,"source_url":"","article_id":"1131412685","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131412685","pubTimestamp":1781708649,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02561":"维昇药业-B"},"translate_title":"VISEN Pharma在2026年6月26日年度股东大会议程中增加了三名非执行董事提名人","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02561":1},"content_text":"VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701, 1788 Square, No. 1788 West Nanjing Road, Jing’an District, Shanghai.\nKey additions to the AGM agenda:  \n1. Ordinary Resolutions 2(e)–2(g) propose the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass and Mr. Michael J. Chang as non-executive directors.  \n2. A revised proxy form—separate from the original proxy form dated 27 April 2026—must be completed for voting on the new resolutions. Submission to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, is required at least 48 hours before the meeting.\nThe supplemental notice states that all other information in the original AGM notice remains unchanged. Voting on all resolutions will be conducted by poll.\nAs at the notice date of 17 June 2026, the board comprises one executive director, two non-executive directors and four independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131412685","isCrawlerRequest":true}